Published in Nat Med on February 01, 1999
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84
Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol (2007) 3.06
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A (2008) 2.57
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med (2000) 2.54
Multiple sclerosis. J Clin Invest (2004) 2.48
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol (2009) 2.41
B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol (2010) 2.17
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.91
Oligodendrocytes: biology and pathology. Acta Neuropathol (2009) 1.81
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A (2006) 1.79
Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med (2007) 1.77
Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol (2000) 1.72
Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology (2012) 1.67
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am J Pathol (2008) 1.58
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate. Ann Neurol (2011) 1.55
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A (2006) 1.53
Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A (2005) 1.50
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm (2015) 1.49
B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol (2011) 1.45
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther (2008) 1.40
Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium-dependent pathway in lyso-PtdCho-induced demyelination. J Neurosci Res (2007) 1.39
Synergistic interactions of lipids and myelin basic protein. Proc Natl Acad Sci U S A (2004) 1.38
B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest (2009) 1.37
The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol (2009) 1.29
To fold or not to fold: modulation and consequences of Hsp90 inhibition. Future Med Chem (2009) 1.29
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28
Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc Natl Acad Sci U S A (2003) 1.27
The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet (2005) 1.26
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain (2008) 1.25
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 1.24
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM. Mol Cell Biol (2005) 1.14
Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc Natl Acad Sci U S A (2002) 1.11
Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol (2001) 1.07
Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med (2000) 1.06
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain (2012) 1.06
Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology. Neurol Neuroimmunol Neuroinflamm (2015) 1.04
Relating domain size distribution to line tension and molecular dipole density in model cytoplasmic myelin lipid monolayers. Proc Natl Acad Sci U S A (2011) 1.03
B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology (2009) 1.03
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther Adv Neurol Disord (2012) 1.03
The Charcot Lecture | beating MS: a story of B cells, with twists and turns. Mult Scler (2014) 1.02
Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci Transl Med (2012) 1.01
The immunopathophysiology of multiple sclerosis. Neurol Clin (2011) 0.99
B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol (2008) 0.98
Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors. Proc Natl Acad Sci U S A (2006) 0.98
Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J Neuroinflammation (2010) 0.97
The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci (1999) 0.97
Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice. J Autoimmun (2011) 0.96
Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci (Landmark Ed) (2009) 0.95
Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol Cell Proteomics (2013) 0.94
Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions. PLoS One (2008) 0.93
Recent neuropathological findings in MS--implications for diagnosis and therapy. J Neurol (2004) 0.93
Critical and off-critical miscibility transitions in model extracellular and cytoplasmic myelin lipid monolayers. Biophys J (2011) 0.92
Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies. Am J Pathol (2007) 0.91
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis. Prog Neurobiol (2008) 0.91
Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration. Pathophysiology (2011) 0.91
Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus. Am J Pathol (2005) 0.90
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis. J Neuroinflammation (2012) 0.89
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis. J Neuroimmunol (2003) 0.88
Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications. Cerebrospinal Fluid Res (2005) 0.88
A cytokine study in children and adolescents with Tourette's disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.88
Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis. Int J Mol Sci (2012) 0.87
Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes. Neuron Glia Biol (2004) 0.87
The role of TNFalpha and lymphotoxin in demyelinating disease. Ann Rheum Dis (1999) 0.87
Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.87
Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J Neuroinflammation (2008) 0.87
B cell-targeted therapies in autoimmunity: rationale and progress. F1000 Biol Rep (2009) 0.87
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Mediators Inflamm (2013) 0.86
Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Arch Neurol (2010) 0.86
B cells in multiple sclerosis. Front Biosci (2004) 0.86
Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF. J Neuroimmunol (2010) 0.86
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. J Neurol (2007) 0.86
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A (2016) 0.85
B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice. J Autoimmun (2008) 0.85
Remembering MOG: autoantibody mediated demyelination in multiple sclerosis? Nat Med (1999) 0.85
Lipid domains control myelin basic protein adsorption and membrane interactions between model myelin lipid bilayers. Proc Natl Acad Sci U S A (2014) 0.84
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation. Front Immunol (2015) 0.84
Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland. Exp Eye Res (2009) 0.84
Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Drug Dev Res (2014) 0.84
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis. Front Immunol (2016) 0.83
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases. Front Immunol (2015) 0.83
Evolution of MS lesions to black holes under DNA vaccine treatment. J Neurol (2012) 0.82
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. J Neuroinflammation (2013) 0.82
Microglial Fc receptors mediate physiological changes resulting from antibody cross-linking of myelin oligodendrocyte glycoprotein. J Neuroimmunol (2008) 0.82
Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients. J Immunol (2010) 0.82
Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death. PLoS One (2013) 0.82
Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice. Neurobiol Dis (2008) 0.81
Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis. Immunology (2002) 0.81
What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? Int J Mol Sci (2012) 0.81
Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm (2013) 0.81
Clinical implications of neuropathological findings in multiple sclerosis. J Neurol (2005) 0.81
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. Genes Immun (2013) 0.80
Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity. Eur J Immunol (2013) 0.80
Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. Mol Vis (2013) 0.80
Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2. BMC Med Genomics (2008) 0.80
Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients? Front Cell Infect Microbiol (2012) 0.79
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology (2008) 3.68
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol (1988) 3.63
Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med (2000) 3.20
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet (1996) 2.98
A simple method for DNA purification from peripheral blood. Anal Biochem (1988) 2.98
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med (1983) 2.93
Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science (1983) 2.91
Observations on viral demyelinating encephalomyelitis. Canine distemper. Lab Invest (1972) 2.88
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med (1994) 2.70
The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol (1995) 2.57
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med (1997) 2.51
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50
Late complications of immune deviation therapy in a nonhuman primate. Science (1996) 2.30
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol (2001) 2.27
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med (1980) 2.21
Electron microscopic observations on the cerebellar cortex in kuru. J Neurol Sci (1969) 2.14
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol (1986) 2.06
Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest (1990) 2.03
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet (2003) 2.02
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest (1991) 2.01
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95
Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab Invest (1970) 1.93
GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron (1996) 1.91
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol (1991) 1.84
Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest (1984) 1.83
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology (1993) 1.81
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol (2001) 1.78
T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol (1995) 1.78
Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol (1999) 1.77
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
An ultrastructural study of experimental demyelination and remyelination. I. Acute experimental allergic encephalomyelitis in the peripheral nervous system. Lab Invest (1969) 1.73
Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol (1991) 1.73
Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol (1990) 1.71
Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest (1990) 1.67
Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A (1991) 1.65
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet (1998) 1.63
A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell (1989) 1.63
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58
On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol (1985) 1.56
Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun (2006) 1.56
Axons: isolation from mammalian central nervous system. Science (1972) 1.55
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest (1995) 1.54
The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol (1991) 1.53
On the development of CNS lesions in natural canine distemper encephalomyelitis. J Neurol Sci (1976) 1.53
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52
Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology (1971) 1.50
Neuroimmunology I: Immunoregulation in neurological disease. Ann Neurol (1982) 1.48
Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol (1983) 1.45
Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. Lab Invest (1974) 1.44
Genetic basis for clinical expression in multiple sclerosis. Brain (2002) 1.43
Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43
Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol (1988) 1.42
Ultrastructure of measles virus in cultures of hamster cerebellum. J Virol (1969) 1.42
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis. J Neuropathol Exp Neurol (1975) 1.40
Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc Natl Acad Sci U S A (1986) 1.38
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain (2008) 1.37
Reovirus type 3 encephalitis--a virologic and ultrastructural study. J Neuropathol Exp Neurol (1973) 1.36
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today (1994) 1.35
Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen. J Neuroimmunol (1983) 1.33
Multiple sclerosis susceptibility alleles in African Americans. Genes Immun (2009) 1.32
Mechanisms of immune injury in multiple sclerosis. Brain Pathol (1996) 1.30
Experimental allergic encephalomyelitis. An electron microscopic study. Am J Pathol (1966) 1.28
Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci (1994) 1.27
Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med (1990) 1.27
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med (Berl) (1997) 1.26
Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest (1981) 1.25
Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest (1980) 1.24
Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol (1989) 1.23
Cytochalasin B inhibits the maturation of measles virus. Virology (1983) 1.22
In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest (1994) 1.20
An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system. Lab Invest (1969) 1.20
Glial bridges and Schwann cell migration during chronic demyelination in the C.N.S. J Neurocytol (1978) 1.20
Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol (1995) 1.20
Taxol-induced neuropathy: short-term effects of local injection. J Neurocytol (1984) 1.19
Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol (1980) 1.19
Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am J Pathol (1998) 1.19
Ultrastructural study of long-term measles infection in cultures of hamster dorsal-root ganglion. J Virol (1971) 1.18
On the association between microtubules and mitochondria within axons. Brain Res (1971) 1.18
Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol (1995) 1.18
Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest (1984) 1.17
Vesicular disruption of myelin in autoimmune demyelination. J Neurol Sci (1975) 1.16